These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35364502)

  • 1. Clinical use of tissue plasminogen activator for systemic thrombolysis in dogs and cats.
    Diaz DM; Scansen BA; Lake Z; Shropshire S; Orton EC; Guillaumin J
    J Vet Cardiol; 2022 Jun; 41():154-164. PubMed ID: 35364502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis with tissue plasminogen activator (TPA) in feline acute aortic thromboembolism: a retrospective study of 16 cases.
    Guillaumin J; Gibson RM; Goy-Thollot I; Bonagura JD
    J Feline Med Surg; 2019 Apr; 21(4):340-346. PubMed ID: 29807505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilateral lysis of aortic saddle thrombus with early tissue plasminogen activator (BLASTT): a prospective, randomized, placebo-controlled study in feline acute aortic thromboembolism.
    Guillaumin J; DeFrancesco TC; Scansen BA; Quinn R; Whelan M; Hanel R; Goy-Thollot I; Bublot I; Robertson JB; Bonagura JD
    J Feline Med Surg; 2022 Dec; 24(12):e535-e545. PubMed ID: 36350753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog.
    Clare AC; Kraje BJ
    J Am Vet Med Assoc; 1998 Feb; 212(4):539-43. PubMed ID: 9491162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue Plasminogen Activator Use in Children: Bleeding Complications and Thrombus Resolution.
    Ansah DA; Patel KN; Montegna L; Nicholson GT; Ehrlich AC; Petit CJ
    J Pediatr; 2016 Apr; 171():67-72.e1-2. PubMed ID: 26707578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Administration of fenoldopam in critically ill small animal patients with acute kidney injury: 28 dogs and 34 cats (2008-2012).
    Nielsen LK; Bracker K; Price LL
    J Vet Emerg Crit Care (San Antonio); 2015; 25(3):396-404. PubMed ID: 25854861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of tissue plasminogen activator in 11 cats with arterial thromboembolism.
    Welch KM; Rozanski EA; Freeman LM; Rush JE
    J Feline Med Surg; 2010 Feb; 12(2):122-8. PubMed ID: 19740689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feline aortic thromboemboli and the potential utility of thrombolytic therapy with tissue plasminogen activator.
    Pion PD
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):79-86. PubMed ID: 3128906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.
    Yasuda T; Gold HK; Leinbach RC; Saito T; Guerrero JL; Jang IK; Holt R; Fallon JT; Collen D
    J Am Coll Cardiol; 1990 Dec; 16(7):1728-35. PubMed ID: 2123910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Management of Urinary Bladder Clot with Intravesical Tissue Plasminogen Activator Infusion in a Cat.
    Young CS; Racette M; Todd JM
    J Am Anim Hosp Assoc; 2021 May; 57(3):. PubMed ID: 33770160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide dismutase decreases reperfusion arrhythmias and preserves myocardial function during thrombolysis with tissue plasminogen activator.
    Mehta JL; Nichols WW; Saldeen TG; Chandna VK; Nicolini FA; Lawson DL; ter Riet MF
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):112-20. PubMed ID: 1696653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of a mutant tissue-type plasminogen activator, YM866, with a tissue-type plasminogen activator in a canine model of femoral arterial thrombosis.
    Kawasaki T; Kaku S; Sakai Y; Takenaka T
    J Pharm Pharmacol; 1996 Oct; 48(10):1041-8. PubMed ID: 8953506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolysis with Systemic Recombinant Tissue Plasminogen Activator in Children: A Multicenter Retrospective Study.
    Zengin E; Sarper N; Yazal Erdem A; Odaman Al I; Sezgin Evim M; Yaralı N; Belen B; Akçay A; Türedi Yıldırım A; Karapınar TH; Güneş AM; Aylan Gelen S; Ören H; Olcay L; Baytan B; Gülen H; Öztürk G; Orhan MF; Oymak Y; Akpınar S; Tüfekçi Ö; Albayrak M; Tatlı Güneş B; Canpolat A; Özbek N
    Turk J Haematol; 2021 Dec; 38(4):294-305. PubMed ID: 34431642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative thrombolytic properties of tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (u-PA) and K1K2Pu (a t-PA/u-PA chimera) in a combined arterial and venous thrombosis model in the dog.
    Lu HR; Wu Z; Pauwels P; Lijnen HR; Collen D
    J Am Coll Cardiol; 1992 May; 19(6):1350-9. PubMed ID: 1342779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of tissue plasminogen activator in catheters used for extracorporeal renal replacement therapy.
    Langston C; Eatroff A; Poeppel K
    J Vet Intern Med; 2014; 28(2):270-6. PubMed ID: 24438008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of tissue-type plasminogen activator-induced thrombolysis and prevention of reocclusion by sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)- ethylidene]-6,11-dihydrodibenz[b,e]oxepine-2-carboxylate monohydrate in a canine model of femoral thrombosis.
    Higo K; Karasawa A; Kubo K
    Arzneimittelforschung; 1991 Dec; 41(12):1251-5. PubMed ID: 1815525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of factor XIIIa in a canine model of coronary thrombosis: effect on reperfusion and acute reocclusion after recombinant tissue-type plasminogen activator.
    Shebuski RJ; Sitko GR; Claremon DA; Baldwin JJ; Remy DC; Stern AM
    Blood; 1990 Apr; 75(7):1455-9. PubMed ID: 1969293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of reocclusion following tissue type plasminogen activator-induced thrombolysis by the RGD-containing peptide, echistatin, in a canine model of coronary thrombosis.
    Holahan MA; Mellott MJ; Garsky VM; Shebuski RJ
    Pharmacology; 1991; 42(6):340-8. PubMed ID: 1946598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented pulse-spray thrombolysis with tPA by early pulsed intrathrombic plasminogen enrichment.
    Lim GM; Bookstein JJ
    J Vasc Interv Radiol; 1998; 9(4):618-25. PubMed ID: 9684833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations and associated disease syndromes in dogs with cranial vena cava thrombosis: 17 cases (1989-1996).
    Palmer KG; King LG; Van Winkle TJ
    J Am Vet Med Assoc; 1998 Jul; 213(2):220-4. PubMed ID: 9676591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.